On December 20, 2021, BeiGene Bioisland Innovation Center was officially launched in Guangzhou. RecoRNA has become one of the first batches of start-ups to settle in the innovation center. A simple yet grand signing ceremony was held on opening day.
BeiGene Bioisland Innovation Center (BIC) in Guangzhou enables scientists and entrepreneurs to accelerate the development of highly differentiated, cutting-edge medical innovations. The BIC is an innovator-centric incubator built on BeiGene’s goal of supporting the exploration of new paths to meet patient needs around the world.
The BIC is located in the Guangdong-Hong Kong-Macau Greater Bay Area, an emerging global biotechnology hub, and will feature a comprehensive research infrastructure and professional management team. The incubator will be equipped with state-of-the-art laboratory infrastructure and comprehensive research capabilities that enable scientists and entrepreneurs to get their ideas off the ground. In addition, scientists and entrepreneurs at the BIC will have potential access to support from BeiGene on full industry value chain integration.
The comprehensive, advanced technology platform at the BIC will allow innovators more autonomy in development, and integrated services to position them for growth.
About BeiGene
BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide.
